Press "Enter" to skip to content

HalioDx, Genecast Ink Agreement to Distribute Early-Stage Colon Cancer Test in China – 360Dx

admin 0

HalioDx, Genecast Ink Agreement to Distribute Early-Stage Colon Cancer Test in China  360Dx

HalioDx said that Chinese oncologists will gain access to its Immunoscore assay for predicting the risk of recurrence of early-stage colon cancer.

“colorectal cancer” – Google News

(Visited 1 times, 1 visits today)

Leave a Reply

Your email address will not be published. Required fields are marked *